Surgical management of novacor drive-line exit site infections

Michael K. Pasque, Tina Hanselman, Kim Shelton, Beth A. Kehoe-Huck, Robyn Hedges, Stephen D. Cassivi, Gregory A. Ewald, Joseph G. Rogers

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Implantable left ventricular assist device (LVAD) drive-line exit site infection, an expected consequence of currently available device use, continues to be a significant limiting factor in long-term support. We theorize that the mechanism behind the establishment of the most chronic exit site infections involves a shearing torsion injury that disrupts the tissue adherence interface with the drive-line. The resulting neo-epithelialized drainage tract prevents permanent clearance of the infection with antibiotics alone. The proposed treatment strategy of established infections involves aggressive surgical excision of the involved exit site.

Original languageEnglish (US)
Pages (from-to)1267-1268
Number of pages2
JournalAnnals of Thoracic Surgery
Volume74
Issue number4
DOIs
StatePublished - Oct 1 2002
Externally publishedYes

Fingerprint

Infection
Heart-Assist Devices
Drainage
Anti-Bacterial Agents
Equipment and Supplies
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Pasque, M. K., Hanselman, T., Shelton, K., Kehoe-Huck, B. A., Hedges, R., Cassivi, S. D., ... Rogers, J. G. (2002). Surgical management of novacor drive-line exit site infections. Annals of Thoracic Surgery, 74(4), 1267-1268. https://doi.org/10.1016/S0003-4975(02)03752-9

Surgical management of novacor drive-line exit site infections. / Pasque, Michael K.; Hanselman, Tina; Shelton, Kim; Kehoe-Huck, Beth A.; Hedges, Robyn; Cassivi, Stephen D.; Ewald, Gregory A.; Rogers, Joseph G.

In: Annals of Thoracic Surgery, Vol. 74, No. 4, 01.10.2002, p. 1267-1268.

Research output: Contribution to journalArticle

Pasque, MK, Hanselman, T, Shelton, K, Kehoe-Huck, BA, Hedges, R, Cassivi, SD, Ewald, GA & Rogers, JG 2002, 'Surgical management of novacor drive-line exit site infections', Annals of Thoracic Surgery, vol. 74, no. 4, pp. 1267-1268. https://doi.org/10.1016/S0003-4975(02)03752-9
Pasque MK, Hanselman T, Shelton K, Kehoe-Huck BA, Hedges R, Cassivi SD et al. Surgical management of novacor drive-line exit site infections. Annals of Thoracic Surgery. 2002 Oct 1;74(4):1267-1268. https://doi.org/10.1016/S0003-4975(02)03752-9
Pasque, Michael K. ; Hanselman, Tina ; Shelton, Kim ; Kehoe-Huck, Beth A. ; Hedges, Robyn ; Cassivi, Stephen D. ; Ewald, Gregory A. ; Rogers, Joseph G. / Surgical management of novacor drive-line exit site infections. In: Annals of Thoracic Surgery. 2002 ; Vol. 74, No. 4. pp. 1267-1268.
@article{2f3aea7bf8c74168be68344fb0737d54,
title = "Surgical management of novacor drive-line exit site infections",
abstract = "Implantable left ventricular assist device (LVAD) drive-line exit site infection, an expected consequence of currently available device use, continues to be a significant limiting factor in long-term support. We theorize that the mechanism behind the establishment of the most chronic exit site infections involves a shearing torsion injury that disrupts the tissue adherence interface with the drive-line. The resulting neo-epithelialized drainage tract prevents permanent clearance of the infection with antibiotics alone. The proposed treatment strategy of established infections involves aggressive surgical excision of the involved exit site.",
author = "Pasque, {Michael K.} and Tina Hanselman and Kim Shelton and Kehoe-Huck, {Beth A.} and Robyn Hedges and Cassivi, {Stephen D.} and Ewald, {Gregory A.} and Rogers, {Joseph G.}",
year = "2002",
month = "10",
day = "1",
doi = "10.1016/S0003-4975(02)03752-9",
language = "English (US)",
volume = "74",
pages = "1267--1268",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Surgical management of novacor drive-line exit site infections

AU - Pasque, Michael K.

AU - Hanselman, Tina

AU - Shelton, Kim

AU - Kehoe-Huck, Beth A.

AU - Hedges, Robyn

AU - Cassivi, Stephen D.

AU - Ewald, Gregory A.

AU - Rogers, Joseph G.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Implantable left ventricular assist device (LVAD) drive-line exit site infection, an expected consequence of currently available device use, continues to be a significant limiting factor in long-term support. We theorize that the mechanism behind the establishment of the most chronic exit site infections involves a shearing torsion injury that disrupts the tissue adherence interface with the drive-line. The resulting neo-epithelialized drainage tract prevents permanent clearance of the infection with antibiotics alone. The proposed treatment strategy of established infections involves aggressive surgical excision of the involved exit site.

AB - Implantable left ventricular assist device (LVAD) drive-line exit site infection, an expected consequence of currently available device use, continues to be a significant limiting factor in long-term support. We theorize that the mechanism behind the establishment of the most chronic exit site infections involves a shearing torsion injury that disrupts the tissue adherence interface with the drive-line. The resulting neo-epithelialized drainage tract prevents permanent clearance of the infection with antibiotics alone. The proposed treatment strategy of established infections involves aggressive surgical excision of the involved exit site.

UR - http://www.scopus.com/inward/record.url?scp=0036799760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036799760&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(02)03752-9

DO - 10.1016/S0003-4975(02)03752-9

M3 - Article

VL - 74

SP - 1267

EP - 1268

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -